⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3196665 | 0.87 | — | — | |
| SCHEMBL6556969 | 0.84 | — | — | |
| SCHEMBL28850965 | 0.74 | — | — | |
| SCHEMBL28850967 | 0.74 | — | — | |
| SCHEMBL16820919 | 0.73 | — | — | |
| SCHEMBL16820705 | 0.73 | — | — | |
| SCHEMBL5395212 | 0.73 | — | — | |
| SCHEMBL5773265 | 0.71 | — | — | |
| SCHEMBL10314780 | 0.71 | — | — | |
| SCHEMBL10314775 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3929207-B1 | PEPTIDE FTTFTVT FOR USE IN TREATING FIBROSIS | UNIV TEXAS (US) | 2024-07-17 | — | — | EP | claimed |
| EP-3929207-A1 | INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES | Board of Regents, The University of Texas System (US) | 2021-12-29 | — | — | EP | claimed |
| US-20180086791-A1 | INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES | UNIV TEXAS (US) | 2018-03-29 | — | — | US | claimed |
| EP-3929207-B1 | PEPTIDE FTTFTVT FOR USE IN TREATING FIBROSIS | UNIV TEXAS (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240067713-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC LUNG DISEASES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-02-29 | — | — | US | disclosed |
| US-20240059736-A1 | INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-02-22 | — | — | US | disclosed |
| US-11905336-B2 | Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis | LUNG THERAPEUTICS, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| US-20240018186-A1 | MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS | LUNG THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | US | disclosed |
| WO-2024015857-A2 | MODIFIED CAVEOLIN-1 PEPTIDE FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF | LUNG THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| US-11787838-B2 | Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis | LUNG THERAPEUTICS, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-11780879-B2 | Inhibition of pulmonary fibrosis with nutlin-3A and peptides | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-10-10 | — | — | US | disclosed |
| WO-2003012395-A2 | EARLY DETECTION OF MYCOBACTERIAL DISEASE USING PEPTIDES | NEW YORK UNIVERSITY (US) | 2003-02-13 | — | — | WO | disclosed |
| US-20030027768-A1 | Anti-invasive and anti-angiogenic compositions | MAZAR ANDREW P (US) | 2003-02-06 | — | — | US | disclosed |
| WO-2002069885-A2 | ANTI-INVASIVE AND ANTI-ANGIOGENIC COMPOSITIONS AND METHODS FOR TREATING BRAIN TUMORS AND OTHER DISEASES | ANGSTROM PHARMACEUTICALS, INC. (US) | 2002-09-12 | — | — | WO | disclosed |
| WO-2002064621-A2 | HISTIDINE PROLINE RICH GLYCOPROTEIN (HPRG) AS AN ANTI-ANGIOGENIC AND ANTI-TUMOR AGENT | ATTENUON, LLC (US) | 2002-08-22 | — | — | WO | disclosed |
| WO-2002014369-A2 | HUMAN KININOGEN D5 DOMAIN POLYPEPTIDES AND THEIR USE | ATTENUON, LLC (US) | 2002-02-21 | — | — | WO | disclosed |
| WO-2001098343-A2 | CONSERVED DIAPHANOUS-RELATED FORMIN AUTOREGULATORY DOMAIN (DAD) | VAN ANDEL INSTITUTE (US) | 2001-12-27 | — | — | WO | disclosed |
| US-5994309-A | OCTAPEPTIDE; ANTITUMOR AGENT | ANGSTROM PHARMACEUTICALS, INC. (US) | 1999-11-30 | — | — | US | disclosed |
| EP-0950096-A1 | ANTI-INVASIVE AND ANTI-ANGIOGENIC UROKINASE FRAGMENTS AND THEIR USE | Angstrom Pharmaceuticals, inc. (US) | 1999-10-20 | — | — | EP | disclosed |
| WO-1999005263-A1 | ANTI-INVASIVE AND ANTI-ANGIOGENIC UROKINASE FRAGMENTS AND THEIR USE | ANGSTROM PHARMACEUTICALS, INC. (US) | 1999-02-04 | — | — | WO | disclosed |